Industry Research Reports

Home > Reports > Pharma & Healthcare > Intravenous Injection Immunoglobulin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Intravenous Injection Immunoglobulin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-12

Pages: 107 Pages

Report ld: 2625062

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Intravenous Injection Immunoglobulin was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Intravenous Injection Immunoglobulin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Intravenous Injection Immunoglobulin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Intravenous Injection Immunoglobulin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Intravenous Injection Immunoglobulin include Boya-Bio, Beijing Tiantan Biological Products, Hualan Bio, Guangdong Shuagnlin Bio-pharmacy, Weiguang Biological, Sinopharm, Shanghai RAAS, CTBB and Nanyue Biopharming, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravenous Injection Immunoglobulin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Intravenous Injection Immunoglobulin by region & country, by Type, and by Application.

The Intravenous Injection Immunoglobulin market size, estimations, and forecasts are provided in terms of sales volume (L) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Injection Immunoglobulin.

Market Segmentation

Report Metric
Details
Report Title
Intravenous Injection Immunoglobulin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Intravenous Injection Immunoglobulin Companies Covered
Boya-Bio, Beijing Tiantan Biological Products, Hualan Bio, Guangdong Shuagnlin Bio-pharmacy, Weiguang Biological, Sinopharm, Shanghai RAAS, CTBB, Nanyue Biopharming
Global Intravenous Injection Immunoglobulin Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Intravenous Injection Immunoglobulin Market, Segment by Type
1g/20ml

1.25g/25ml

2.5g/50ml

5g/100ml

10g/200ml
Global Intravenous Injection Immunoglobulin Market, Segment by Application
Hospital

Clinic

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Intravenous Injection Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Intravenous Injection Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Intravenous Injection Immunoglobulin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Intravenous Injection Immunoglobulin Product Introduction
    1.2 Global Intravenous Injection Immunoglobulin Market Size Forecast
        1.2.1 Global Intravenous Injection Immunoglobulin Sales Value (2019-2030)
        1.2.2 Global Intravenous Injection Immunoglobulin Sales Volume (2019-2030)
        1.2.3 Global Intravenous Injection Immunoglobulin Sales Price (2019-2030)
    1.3 Intravenous Injection Immunoglobulin Market Trends & Drivers
        1.3.1 Intravenous Injection Immunoglobulin Industry Trends
        1.3.2 Intravenous Injection Immunoglobulin Market Drivers & Opportunity
        1.3.3 Intravenous Injection Immunoglobulin Market Challenges
        1.3.4 Intravenous Injection Immunoglobulin Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Intravenous Injection Immunoglobulin Players Revenue Ranking (2023)
    2.2 Global Intravenous Injection Immunoglobulin Revenue by Company (2019-2024)
    2.3 Global Intravenous Injection Immunoglobulin Players Sales Volume Ranking (2023)
    2.4 Global Intravenous Injection Immunoglobulin Sales Volume by Company Players (2019-2024)
    2.5 Global Intravenous Injection Immunoglobulin Average Price by Company (2019-2024)
    2.6 Key Manufacturers Intravenous Injection Immunoglobulin Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Intravenous Injection Immunoglobulin Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Intravenous Injection Immunoglobulin
    2.9 Intravenous Injection Immunoglobulin Market Competitive Analysis
        2.9.1 Intravenous Injection Immunoglobulin Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Intravenous Injection Immunoglobulin Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Injection Immunoglobulin as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 1g/20ml
        3.1.2 1.25g/25ml
        3.1.3 2.5g/50ml
        3.1.4 5g/100ml
        3.1.5 10g/200ml
    3.2 Global Intravenous Injection Immunoglobulin Sales Value by Type
        3.2.1 Global Intravenous Injection Immunoglobulin Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Intravenous Injection Immunoglobulin Sales Value, by Type (2019-2030)
        3.2.3 Global Intravenous Injection Immunoglobulin Sales Value, by Type (%) (2019-2030)
    3.3 Global Intravenous Injection Immunoglobulin Sales Volume by Type
        3.3.1 Global Intravenous Injection Immunoglobulin Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Intravenous Injection Immunoglobulin Sales Volume, by Type (2019-2030)
        3.3.3 Global Intravenous Injection Immunoglobulin Sales Volume, by Type (%) (2019-2030)
    3.4 Global Intravenous Injection Immunoglobulin Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Clinic
        4.1.3 Others
    4.2 Global Intravenous Injection Immunoglobulin Sales Value by Application
        4.2.1 Global Intravenous Injection Immunoglobulin Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Intravenous Injection Immunoglobulin Sales Value, by Application (2019-2030)
        4.2.3 Global Intravenous Injection Immunoglobulin Sales Value, by Application (%) (2019-2030)
    4.3 Global Intravenous Injection Immunoglobulin Sales Volume by Application
        4.3.1 Global Intravenous Injection Immunoglobulin Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Intravenous Injection Immunoglobulin Sales Volume, by Application (2019-2030)
        4.3.3 Global Intravenous Injection Immunoglobulin Sales Volume, by Application (%) (2019-2030)
    4.4 Global Intravenous Injection Immunoglobulin Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Intravenous Injection Immunoglobulin Sales Value by Region
        5.1.1 Global Intravenous Injection Immunoglobulin Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Intravenous Injection Immunoglobulin Sales Value by Region (2019-2024)
        5.1.3 Global Intravenous Injection Immunoglobulin Sales Value by Region (2025-2030)
        5.1.4 Global Intravenous Injection Immunoglobulin Sales Value by Region (%), (2019-2030)
    5.2 Global Intravenous Injection Immunoglobulin Sales Volume by Region
        5.2.1 Global Intravenous Injection Immunoglobulin Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Intravenous Injection Immunoglobulin Sales Volume by Region (2019-2024)
        5.2.3 Global Intravenous Injection Immunoglobulin Sales Volume by Region (2025-2030)
        5.2.4 Global Intravenous Injection Immunoglobulin Sales Volume by Region (%), (2019-2030)
    5.3 Global Intravenous Injection Immunoglobulin Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Intravenous Injection Immunoglobulin Sales Value, 2019-2030
        5.4.2 North America Intravenous Injection Immunoglobulin Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Intravenous Injection Immunoglobulin Sales Value, 2019-2030
        5.5.2 Europe Intravenous Injection Immunoglobulin Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Intravenous Injection Immunoglobulin Sales Value, 2019-2030
        5.6.2 Asia Pacific Intravenous Injection Immunoglobulin Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Intravenous Injection Immunoglobulin Sales Value, 2019-2030
        5.7.2 South America Intravenous Injection Immunoglobulin Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Intravenous Injection Immunoglobulin Sales Value, 2019-2030
        5.8.2 Middle East & Africa Intravenous Injection Immunoglobulin Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Intravenous Injection Immunoglobulin Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Intravenous Injection Immunoglobulin Sales Value
        6.2.1 Key Countries/Regions Intravenous Injection Immunoglobulin Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Intravenous Injection Immunoglobulin Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Intravenous Injection Immunoglobulin Sales Value, 2019-2030
        6.3.2 United States Intravenous Injection Immunoglobulin Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Intravenous Injection Immunoglobulin Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Intravenous Injection Immunoglobulin Sales Value, 2019-2030
        6.4.2 Europe Intravenous Injection Immunoglobulin Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Intravenous Injection Immunoglobulin Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Intravenous Injection Immunoglobulin Sales Value, 2019-2030
        6.5.2 China Intravenous Injection Immunoglobulin Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Intravenous Injection Immunoglobulin Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Intravenous Injection Immunoglobulin Sales Value, 2019-2030
        6.6.2 Japan Intravenous Injection Immunoglobulin Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Intravenous Injection Immunoglobulin Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Intravenous Injection Immunoglobulin Sales Value, 2019-2030
        6.7.2 South Korea Intravenous Injection Immunoglobulin Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Intravenous Injection Immunoglobulin Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Intravenous Injection Immunoglobulin Sales Value, 2019-2030
        6.8.2 Southeast Asia Intravenous Injection Immunoglobulin Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Intravenous Injection Immunoglobulin Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Intravenous Injection Immunoglobulin Sales Value, 2019-2030
        6.9.2 India Intravenous Injection Immunoglobulin Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Intravenous Injection Immunoglobulin Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Boya-Bio
        7.1.1 Boya-Bio Company Information
        7.1.2 Boya-Bio Introduction and Business Overview
        7.1.3 Boya-Bio Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Boya-Bio Intravenous Injection Immunoglobulin Product Offerings
        7.1.5 Boya-Bio Recent Development
    7.2 Beijing Tiantan Biological Products
        7.2.1 Beijing Tiantan Biological Products Company Information
        7.2.2 Beijing Tiantan Biological Products Introduction and Business Overview
        7.2.3 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Product Offerings
        7.2.5 Beijing Tiantan Biological Products Recent Development
    7.3 Hualan Bio
        7.3.1 Hualan Bio Company Information
        7.3.2 Hualan Bio Introduction and Business Overview
        7.3.3 Hualan Bio Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Hualan Bio Intravenous Injection Immunoglobulin Product Offerings
        7.3.5 Hualan Bio Recent Development
    7.4 Guangdong Shuagnlin Bio-pharmacy
        7.4.1 Guangdong Shuagnlin Bio-pharmacy Company Information
        7.4.2 Guangdong Shuagnlin Bio-pharmacy Introduction and Business Overview
        7.4.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Product Offerings
        7.4.5 Guangdong Shuagnlin Bio-pharmacy Recent Development
    7.5 Weiguang Biological
        7.5.1 Weiguang Biological Company Information
        7.5.2 Weiguang Biological Introduction and Business Overview
        7.5.3 Weiguang Biological Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Weiguang Biological Intravenous Injection Immunoglobulin Product Offerings
        7.5.5 Weiguang Biological Recent Development
    7.6 Sinopharm
        7.6.1 Sinopharm Company Information
        7.6.2 Sinopharm Introduction and Business Overview
        7.6.3 Sinopharm Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Sinopharm Intravenous Injection Immunoglobulin Product Offerings
        7.6.5 Sinopharm Recent Development
    7.7 Shanghai RAAS
        7.7.1 Shanghai RAAS Company Information
        7.7.2 Shanghai RAAS Introduction and Business Overview
        7.7.3 Shanghai RAAS Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Shanghai RAAS Intravenous Injection Immunoglobulin Product Offerings
        7.7.5 Shanghai RAAS Recent Development
    7.8 CTBB
        7.8.1 CTBB Company Information
        7.8.2 CTBB Introduction and Business Overview
        7.8.3 CTBB Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 CTBB Intravenous Injection Immunoglobulin Product Offerings
        7.8.5 CTBB Recent Development
    7.9 Nanyue Biopharming
        7.9.1 Nanyue Biopharming Company Information
        7.9.2 Nanyue Biopharming Introduction and Business Overview
        7.9.3 Nanyue Biopharming Intravenous Injection Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Nanyue Biopharming Intravenous Injection Immunoglobulin Product Offerings
        7.9.5 Nanyue Biopharming Recent Development

 8 Industry Chain Analysis
    8.1 Intravenous Injection Immunoglobulin Industrial Chain
    8.2 Intravenous Injection Immunoglobulin Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Intravenous Injection Immunoglobulin Sales Model
        8.5.2 Sales Channel
        8.5.3 Intravenous Injection Immunoglobulin Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Intravenous Injection Immunoglobulin Market Trends
    Table 2. Intravenous Injection Immunoglobulin Market Drivers & Opportunity
    Table 3. Intravenous Injection Immunoglobulin Market Challenges
    Table 4. Intravenous Injection Immunoglobulin Market Restraints
    Table 5. Global Intravenous Injection Immunoglobulin Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Intravenous Injection Immunoglobulin Revenue Market Share by Company (2019-2024)
    Table 7. Global Intravenous Injection Immunoglobulin Sales Volume by Company (2019-2024) & (L)
    Table 8. Global Intravenous Injection Immunoglobulin Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Intravenous Injection Immunoglobulin Price by Company (2019-2024) & (US$/ml)
    Table 10. Key Manufacturers Intravenous Injection Immunoglobulin Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Intravenous Injection Immunoglobulin Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Intravenous Injection Immunoglobulin
    Table 13. Global Intravenous Injection Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Injection Immunoglobulin as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Intravenous Injection Immunoglobulin Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Intravenous Injection Immunoglobulin Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Intravenous Injection Immunoglobulin Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Intravenous Injection Immunoglobulin Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Intravenous Injection Immunoglobulin Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Intravenous Injection Immunoglobulin Sales Volume by Type: 2019 VS 2023 VS 2030 (L)
    Table 22. Global Intravenous Injection Immunoglobulin Sales Volume by Type (2019-2024) & (L)
    Table 23. Global Intravenous Injection Immunoglobulin Sales Volume by Type (2025-2030) & (L)
    Table 24. Global Intravenous Injection Immunoglobulin Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Intravenous Injection Immunoglobulin Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Intravenous Injection Immunoglobulin Price by Type (2019-2024) & (US$/ml)
    Table 27. Global Intravenous Injection Immunoglobulin Price by Type (2025-2030) & (US$/ml)
    Table 28. Global Intravenous Injection Immunoglobulin Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Intravenous Injection Immunoglobulin Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Intravenous Injection Immunoglobulin Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Intravenous Injection Immunoglobulin Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Intravenous Injection Immunoglobulin Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Intravenous Injection Immunoglobulin Sales Volume by Application: 2019 VS 2023 VS 2030 (L)
    Table 34. Global Intravenous Injection Immunoglobulin Sales Volume by Application (2019-2024) & (L)
    Table 35. Global Intravenous Injection Immunoglobulin Sales Volume by Application (2025-2030) & (L)
    Table 36. Global Intravenous Injection Immunoglobulin Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Intravenous Injection Immunoglobulin Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Intravenous Injection Immunoglobulin Price by Application (2019-2024) & (US$/ml)
    Table 39. Global Intravenous Injection Immunoglobulin Price by Application (2025-2030) & (US$/ml)
    Table 40. Global Intravenous Injection Immunoglobulin Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Intravenous Injection Immunoglobulin Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Intravenous Injection Immunoglobulin Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Intravenous Injection Immunoglobulin Sales Value by Region (2019-2024) & (%)
    Table 44. Global Intravenous Injection Immunoglobulin Sales Value by Region (2025-2030) & (%)
    Table 45. Global Intravenous Injection Immunoglobulin Sales Volume by Region (L): 2019 VS 2023 VS 2030
    Table 46. Global Intravenous Injection Immunoglobulin Sales Volume by Region (2019-2024) & (L)
    Table 47. Global Intravenous Injection Immunoglobulin Sales Volume by Region (2025-2030) & (L)
    Table 48. Global Intravenous Injection Immunoglobulin Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Intravenous Injection Immunoglobulin Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Intravenous Injection Immunoglobulin Average Price by Region (2019-2024) & (US$/ml)
    Table 51. Global Intravenous Injection Immunoglobulin Average Price by Region (2025-2030) & (US$/ml)
    Table 52. Key Countries/Regions Intravenous Injection Immunoglobulin Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Intravenous Injection Immunoglobulin Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Intravenous Injection Immunoglobulin Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Intravenous Injection Immunoglobulin Sales Volume, (2019-2024) & (L)
    Table 56. Key Countries/Regions Intravenous Injection Immunoglobulin Sales Volume, (2025-2030) & (L)
    Table 57. Boya-Bio Company Information
    Table 58. Boya-Bio Introduction and Business Overview
    Table 59. Boya-Bio Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
    Table 60. Boya-Bio Intravenous Injection Immunoglobulin Product Offerings
    Table 61. Boya-Bio Recent Development
    Table 62. Beijing Tiantan Biological Products Company Information
    Table 63. Beijing Tiantan Biological Products Introduction and Business Overview
    Table 64. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
    Table 65. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Product Offerings
    Table 66. Beijing Tiantan Biological Products Recent Development
    Table 67. Hualan Bio Company Information
    Table 68. Hualan Bio Introduction and Business Overview
    Table 69. Hualan Bio Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
    Table 70. Hualan Bio Intravenous Injection Immunoglobulin Product Offerings
    Table 71. Hualan Bio Recent Development
    Table 72. Guangdong Shuagnlin Bio-pharmacy Company Information
    Table 73. Guangdong Shuagnlin Bio-pharmacy Introduction and Business Overview
    Table 74. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
    Table 75. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Product Offerings
    Table 76. Guangdong Shuagnlin Bio-pharmacy Recent Development
    Table 77. Weiguang Biological Company Information
    Table 78. Weiguang Biological Introduction and Business Overview
    Table 79. Weiguang Biological Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
    Table 80. Weiguang Biological Intravenous Injection Immunoglobulin Product Offerings
    Table 81. Weiguang Biological Recent Development
    Table 82. Sinopharm Company Information
    Table 83. Sinopharm Introduction and Business Overview
    Table 84. Sinopharm Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
    Table 85. Sinopharm Intravenous Injection Immunoglobulin Product Offerings
    Table 86. Sinopharm Recent Development
    Table 87. Shanghai RAAS Company Information
    Table 88. Shanghai RAAS Introduction and Business Overview
    Table 89. Shanghai RAAS Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
    Table 90. Shanghai RAAS Intravenous Injection Immunoglobulin Product Offerings
    Table 91. Shanghai RAAS Recent Development
    Table 92. CTBB Company Information
    Table 93. CTBB Introduction and Business Overview
    Table 94. CTBB Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
    Table 95. CTBB Intravenous Injection Immunoglobulin Product Offerings
    Table 96. CTBB Recent Development
    Table 97. Nanyue Biopharming Company Information
    Table 98. Nanyue Biopharming Introduction and Business Overview
    Table 99. Nanyue Biopharming Intravenous Injection Immunoglobulin Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2019-2024)
    Table 100. Nanyue Biopharming Intravenous Injection Immunoglobulin Product Offerings
    Table 101. Nanyue Biopharming Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Intravenous Injection Immunoglobulin Downstream Customers
    Table 105. Intravenous Injection Immunoglobulin Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Intravenous Injection Immunoglobulin Product Picture
    Figure 2. Global Intravenous Injection Immunoglobulin Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Intravenous Injection Immunoglobulin Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Intravenous Injection Immunoglobulin Sales Volume (2019-2030) & (L)
    Figure 5. Global Intravenous Injection Immunoglobulin Sales Price (2019-2030) & (US$/ml)
    Figure 6. Intravenous Injection Immunoglobulin Report Years Considered
    Figure 7. Global Intravenous Injection Immunoglobulin Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Intravenous Injection Immunoglobulin Players Sales Volume Ranking (2023) & (L)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Intravenous Injection Immunoglobulin Revenue in 2023
    Figure 10. Intravenous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. 1g/20ml Picture
    Figure 12. 1.25g/25ml Picture
    Figure 13. 2.5g/50ml Picture
    Figure 14. 5g/100ml Picture
    Figure 15. 10g/200ml Picture
    Figure 16. Global Intravenous Injection Immunoglobulin Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Intravenous Injection Immunoglobulin Sales Value Market Share by Type, 2023 & 2030
    Figure 18. Global Intravenous Injection Immunoglobulin Sales Volume by Type (2019 VS 2023 VS 2030) & (L)
    Figure 19. Global Intravenous Injection Immunoglobulin Sales Volume Market Share by Type, 2023 & 2030
    Figure 20. Global Intravenous Injection Immunoglobulin Price by Type (2019-2030) & (US$/ml)
    Figure 21. Product Picture of Hospital
    Figure 22. Product Picture of Clinic
    Figure 23. Product Picture of Others
    Figure 24. Global Intravenous Injection Immunoglobulin Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Intravenous Injection Immunoglobulin Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Intravenous Injection Immunoglobulin Sales Volume by Application (2019 VS 2023 VS 2030) & (L)
    Figure 27. Global Intravenous Injection Immunoglobulin Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Intravenous Injection Immunoglobulin Price by Application (2019-2030) & (US$/ml)
    Figure 29. North America Intravenous Injection Immunoglobulin Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Intravenous Injection Immunoglobulin Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Intravenous Injection Immunoglobulin Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Intravenous Injection Immunoglobulin Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Intravenous Injection Immunoglobulin Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Intravenous Injection Immunoglobulin Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Intravenous Injection Immunoglobulin Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Intravenous Injection Immunoglobulin Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Intravenous Injection Immunoglobulin Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Intravenous Injection Immunoglobulin Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Intravenous Injection Immunoglobulin Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Intravenous Injection Immunoglobulin Sales Volume (%), (2019-2030)
    Figure 41. United States Intravenous Injection Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Intravenous Injection Immunoglobulin Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Intravenous Injection Immunoglobulin Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Intravenous Injection Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Intravenous Injection Immunoglobulin Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Intravenous Injection Immunoglobulin Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Intravenous Injection Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Intravenous Injection Immunoglobulin Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Intravenous Injection Immunoglobulin Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Intravenous Injection Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Intravenous Injection Immunoglobulin Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Intravenous Injection Immunoglobulin Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Intravenous Injection Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Intravenous Injection Immunoglobulin Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Intravenous Injection Immunoglobulin Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Intravenous Injection Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Intravenous Injection Immunoglobulin Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Intravenous Injection Immunoglobulin Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Intravenous Injection Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Intravenous Injection Immunoglobulin Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Intravenous Injection Immunoglobulin Sales Value by Application (%), 2023 VS 2030
    Figure 62. Intravenous Injection Immunoglobulin Industrial Chain
    Figure 63. Intravenous Injection Immunoglobulin Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed

Description

The global market for Intravenous Injection Immunoglobulin was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Intravenous Injection Immunoglobulin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Intravenous Injection Immunoglobulin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Intravenous Injection Immunoglobulin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Intravenous Injection Immunoglobulin include Boya-Bio, Beijing Tiantan Biological Products, Hualan Bio, Guangdong Shuagnlin Bio-pharmacy, Weiguang Biological, Sinopharm, Shanghai RAAS, CTBB and Nanyue Biopharming, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravenous Injection Immunoglobulin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Intravenous Injection Immunoglobulin by region & country, by Type, and by Application.

The Intravenous Injection Immunoglobulin market size, estimations, and forecasts are provided in terms of sales volume (L) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Injection Immunoglobulin.

Market Segmentation